Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Crypto Market Surges Ahead of Equities: Dr. Dragosch's Analysis
  2. Why Vitalik Buterin Is ‘Actually Kinda Happy a Lot of the ETFs Are Getting Delayed’
  3. Leading Trader's Analysis: Hesitation on Bitcoin After Recent Retracement
  4. Vertiv Adds 7% On Encouraging Outlook
  5. Binance Research on How Bitcoin NFTs Are Taking the Crypto World by Storm